Literature DB >> 3931344

The effect of nicotine on cultured cells of vascular origin.

E Csonka, A Somogyi, J Augustin, W Haberbosch, G Schettler, H Jellinek.   

Abstract

Monolayers of endothelial, smooth muscle and fibroblastic cells of healthy porcine, bovine or human fetal origin were treated with 10(-4) to 10(-9) M final concentrations of nicotine. The effect was registered as changes in the synthesis and polyimerization of the cytoskeleton. The silver and gold impregnation method produced anisotropy of the synthetic granules and of the final polymers of microtubules and filaments under physiological conditions as revealed by polarization microscopy. Since the orientation of the cells was inhomogeneous in the cultures, the organization of the orientation was expressed as the sum of alternative diagonal and orthogonal measuring of anisotropy by a computerized microraster morphometry system joined to an OPTON cytophotometer. The 8-day-old control and treated cultures were also examined by electronmicroscopy. Nicotine stimulated the synthesis and polyimerization of the cytoskeletal protein. This phenomenon is evident in smooth muscle cells, and partly also in endothelium. Fibroblasts were not influenced by the doses of nicotine tested.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3931344     DOI: 10.1007/bf00709990

Source DB:  PubMed          Journal:  Virchows Arch A Pathol Anat Histopathol        ISSN: 0174-7398


  10 in total

1.  Role of arterial wall cells in sclerogenesis.

Authors:  W H Hauss
Journal:  Ann N Y Acad Sci       Date:  1976       Impact factor: 5.691

Review 2.  Cytoskeleton: definition, structure and gene regulation.

Authors:  K Weber; M Osborn
Journal:  Pathol Res Pract       Date:  1982       Impact factor: 3.250

Review 3.  Role of endothelial integrity in atherosclerosis.

Authors:  S M Schwartz
Journal:  Artery       Date:  1980

4.  The multiple risk factor intervention trial (MRFIT). I. Historical perspective.

Authors:  W J Zukel; O Paul; H W Schnaper
Journal:  Prev Med       Date:  1981-07       Impact factor: 4.018

5.  Quantitative studies of pinocytosis by arterial endothelial and smooth muscle cells in culture.

Authors:  D S Leake; D E Bowyer
Journal:  Exp Mol Pathol       Date:  1981-08       Impact factor: 3.362

6.  Serum cotinine levels in pipe smokers: evidence against nicotine as cause of coronary heart disease.

Authors:  N J Wald; M Idle; J Boreham; A Bailey
Journal:  Lancet       Date:  1981-10-10       Impact factor: 79.321

7.  Atherosclerosis and the arterial smooth muscle cell: Proliferation of smooth muscle is a key event in the genesis of the lesions of atherosclerosis.

Authors:  R Ross; J A Glomset
Journal:  Science       Date:  1973-06-29       Impact factor: 47.728

8.  Circadian blood nicotine concentrations during cigarette smoking.

Authors:  N L Benowitz; F Kuyt; P Jacob
Journal:  Clin Pharmacol Ther       Date:  1982-12       Impact factor: 6.875

9.  Study on the onset of atherosclerotic lesions in human coronary arteries.

Authors:  C Velican; D Velican
Journal:  Med Interne       Date:  1979 Apr-Jun

10.  Maintenance of integrity in aortic endothelium.

Authors:  S M Schwartz; C M Gajdusek; M A Reidy; S C Selden; C C Haudenschild
Journal:  Fed Proc       Date:  1980-07
  10 in total
  3 in total

1.  Effect of chronic nicotine delivery on the proliferation rate of endothelial and smooth muscle cells in experimentally induced vascular wall plaques.

Authors:  T Strohschneider; M Oberhoff; H Hanke; A Hannekum; K R Karsch
Journal:  Clin Investig       Date:  1994-11

2.  Very low nicotine content cigarettes and potential consequences on cardiovascular disease.

Authors:  Danielle L Joel; Rachel L Denlinger; Sarah S Dermody; Dorothy K Hatsukami; Neal L Benowitz; Eric C Donny
Journal:  Curr Cardiovasc Risk Rep       Date:  2012-09-01

Review 3.  Harmful effects of nicotine.

Authors:  Aseem Mishra; Pankaj Chaturvedi; Sourav Datta; Snita Sinukumar; Poonam Joshi; Apurva Garg
Journal:  Indian J Med Paediatr Oncol       Date:  2015 Jan-Mar
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.